Skip to main content
Log in

Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Cytochrome P450 3A7 (CYP3A7) is expressed in the human fetal liver and plays a role in the metabolism of hormones, drugs, and toxic compounds. Genetic variants of CYP3A7 are associated with serum estrone level, bone density, and hepatic CYP3A activity in adults. We analyzed the genetic variations of CYP3A7 in a Korean population. From direct sequencing of all exons and flanking regions of the CYP3A7 gene in 48 Koreans, we found five genetic variants, including three novel variants. One variant, a thymidine insertion in exon 2 (4011insT), causes premature termination of CYP3A7 translation, which may result in a null phenotype. The novel variant was assigned to the CYP3A7*3 allele by the CYP allele nomenclature committee. For further screen of this novel variant in other ethnic populations, we used pyrosequencing to analyze an additional 185 Koreans, 100 African Americans, 100 Caucasians, and 159 Vietnamese for the presence of this variant. The variant was not found in any other individuals, except for one Korean subject. The frequencies of two known functional alleles, CYP3A7*2 and CYP3A7*1C, were 26 and 0%, respectively, in Koreans. The frequencies of the functional CYP3A7 polymorphisms in Koreans were significantly different from those in Caucasians and African Americans. This is the first report of a null-type allele of the CYP3A7 gene. It also provides population-level genetic data on CYP3A7 in Koreans to reveal the wide ethnic variation in CYP3A7 polymorphism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M et al (2001) Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 11:111–121. doi:10.1097/00008571-200103000-00002

    Article  CAS  PubMed  Google Scholar 

  2. Ring JA, Ghabrial H, Ching MS, Smallwood RA, Morgan DJ (1999) Fetal hepatic drug elimination. Pharmacol Ther 84:429–445. doi:10.1016/S0163-7258(99)00046-7

    Article  CAS  PubMed  Google Scholar 

  3. Schuetz JD, Kauma S, Guzelian PS (1993) Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin Invest 92:1018–1024. doi:10.1172/JCI116607

    Article  CAS  PubMed  Google Scholar 

  4. Koch I, Weil R, Wolbold R, Brockmoller J, Hustert E, Burk O et al (2002) Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30:1108–1114. doi:10.1124/dmd.30.10.1108

    Article  CAS  PubMed  Google Scholar 

  5. Sim SC, Edwards RJ, Boobis AR, Ingelman-Sundberg M (2005) CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele. Pharmacogenet Genomics 15:625–631. doi:10.1097/01.fpc.0000171516.84139.89

    Article  CAS  PubMed  Google Scholar 

  6. Burk O, Tegude H, Koch I, Hustert E, Wolbold R, Glaeser H et al (2002) Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 277:24280–24288. doi:10.1074/jbc.M202345200

    Article  CAS  PubMed  Google Scholar 

  7. Schuetz JD, Beach DL, Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11–20. doi:10.1097/00008571-199402000-00002

    Article  CAS  PubMed  Google Scholar 

  8. Bacsi K, Kosa JP, Borgulya G, Balla B, Lazary A, Nagy Z et al (2007) CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women. Calcif Tissue Int 80:154–159. doi:10.1007/s00223-006-0227-8

    Article  CAS  PubMed  Google Scholar 

  9. Rodriguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M (2005) Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers. Clin Pharmacol Ther 77:259–270. doi:10.1016/j.clpt.2004.11.003

    Article  CAS  PubMed  Google Scholar 

  10. Bacsi K, Kosa J, Lazary A, Balla B, Horvath H, Takacs I et al (2007) Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women. Orv Hetil 148:1273–1280. doi:10.1556/OH.2007.28102

    Article  PubMed  Google Scholar 

  11. Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J et al (2005) A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 90:5313–5316. doi:10.1210/jc.2005-0307

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Korea Science and Engineering Foundation (KOSEF) through the Medical Research Center Program funded by the Ministry of Science and Technology (R13-2007-023-00000-0) and by Inje University Research Grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jae-Gook Shin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S.S., Jung, HJ., Park, J.S. et al. Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population. Mol Biol Rep 37, 213–217 (2010). https://doi.org/10.1007/s11033-009-9608-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9608-1

Keywords

Navigation